Form 8-K - Current report:
SEC Accession No. 0001658247-25-000008
Filing Date
2025-09-26
Accepted
2025-09-25 17:36:34
Documents
14
Period of Report
2025-09-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20250925.htm   iXBRL 8-K 29131
2 EX-99.1 crnx-2025925ex991.htm EX-99.1 32702
6 img113038668_0.jpg GRAPHIC 141166
  Complete submission text file 0001658247-25-000008.txt   382148

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20250925.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20250925_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20250925_pre.xml EX-101.PRE 12512
16 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20250925_htm.xml XML 2725
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 251344905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)